Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | AMGN | VRTX | BMY | GILD |
| Company | Arena Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 99.97 | 319.10 | 414.10 | 46.41 | 121.93 |
| High | 100.00 | 321.31 | 424.25 | 47.00 | 124.10 |
| Low | 99.97 | 312.52 | 410.29 | 45.96 | 121.72 |
| Last | 99.99 | 315.59 | 416.25 | 46.63 | 123.40 |
| Change | +0.06 | -4.27 | -0.75 | +0.16 | +0.82 |
| % Change | +0.06% | -1.33% | -0.18% | +0.34% | +0.67% |
| Volume | 5,718,500 | 3,330,200 | 1,331,700 | 11,589,373 | 6,085,300 |
| 20-Day Average Volume | 1,676,465 | 2,346,730 | 1,346,950 | 16,593,141 | 6,942,215 |
| Previous Close | 99.93 | 319.86 | 417.00 | 46.47 | 122.58 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 297.37 | 418.13 | 44.37 | 120.46 |
| 20-Day Raw Stochastic | 99.86% | 78.87% | 45.29% | 91.74% | 88.57% |
| 20-Day Relative Strength | 75.07 | 64.69 | 52.18 | 57.59 | 61.36 |
| Weighted Alpha | -14.40 | +4.26 | -16.24 | -14.21 | +30.28 |
| Today's Opinion | 100% Buy | 56% Buy | 56% Sell | 40% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 56% Sell | 40% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 56% Sell | 100% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +8.08% since 10/30/25 | -0.87% since 10/30/25 | +2.21% since 10/30/25 | +4.19% since 10/30/25 |
| Low | 93.54 on 03/07/22 | 288.00 on 10/31/25 | 403.16 on 11/04/25 | 45.20 on 10/31/25 | 114.02 on 10/31/25 |
| High | 100.00 on 03/10/22 | 322.98 on 11/05/25 | 430.71 on 11/04/25 | 47.00 on 11/06/25 | 124.10 on 11/06/25 |
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | +7.30% since 10/06/25 | +3.31% since 10/06/25 | +3.30% since 10/06/25 | +8.65% since 10/06/25 |
| Low | 92.85 on 02/22/22 | 288.00 on 10/31/25 | 400.86 on 10/07/25 | 42.52 on 10/29/25 | 112.82 on 10/07/25 |
| High | 100.00 on 03/10/22 | 322.98 on 11/05/25 | 432.76 on 10/23/25 | 47.00 on 11/06/25 | 124.61 on 10/21/25 |
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | +10.86% since 08/06/25 | +7.93% since 08/06/25 | +4.04% since 08/06/25 | +11.90% since 08/06/25 |
| Low | 89.03 on 01/25/22 | 269.77 on 09/26/25 | 362.50 on 08/11/25 | 42.52 on 10/29/25 | 108.46 on 10/02/25 |
| High | 100.00 on 03/10/22 | 322.98 on 11/05/25 | 432.76 on 10/23/25 | 49.58 on 08/20/25 | 124.61 on 10/21/25 |
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | +16.70% since 05/06/25 | -7.51% since 05/06/25 | -1.98% since 05/06/25 | +26.07% since 05/06/25 |
| Low | 48.12 on 12/06/21 | 261.43 on 05/14/25 | 362.50 on 08/11/25 | 42.52 on 10/29/25 | 95.29 on 05/08/25 |
| High | 100.00 on 03/10/22 | 322.98 on 11/05/25 | 484.56 on 07/10/25 | 50.76 on 06/11/25 | 124.61 on 10/21/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 172,200,464 | 106,915,040 | 94,601,448 | 152,098,128 |
| Shares Outstanding, K | 61,659 | 538,362 | 256,391 | 2,035,753 | 1,240,807 |
| Annual Sales | 50,000 | 33,424,000,000 | 11,020,100,000 | 48,300,000,000 | 28,754,000,000 |
| Annual Net Income | -616,430,000 | 4,090,000,000 | -535,600,000 | -8,948,000,000 | 480,000,000 |
| Last Quarter Sales | 50,000 | 9,179,000,000 | 2,964,700,000 | 12,222,000,000 | 7,769,000,000 |
| Last Quarter Net Income | -155,610,000 | 1,432,000,000 | 1,032,900,000 | 2,201,000,000 | 3,052,000,000 |
| 60-Month Beta | 0.55 | 0.45 | 0.36 | 0.33 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | 5.64 on 11/04/25 | 4.80 on 11/03/25 | 1.63 on 10/30/25 | 2.47 on 10/30/25 |
| Latest Earnings Date | 05/04/22 | 11/04/25 | 11/03/25 | 10/30/25 | 10/30/25 |
| Most Recent Dividend | N/A | 2.380 on 08/22/25 | N/A | 0.620 on 10/03/25 | 0.790 on 09/15/25 |
| Next Ex-Dividends Date | N/A | 11/21/25 | N/A | 10/03/25 | 12/15/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.57 | 27.54 | 6.95 | 15.02 |